COMMUNIQUÉS West-GlobeNewswire
![GlobalNewswire](/sites/santelog.com/www.santelog.com/themes/santelog/images/nasdacinner.png)
-
New Publication Reviewing Percutaneous PNS in the Management of Chronic Pain Highlights Consistent, Sustained Relief of Pain Across Multiple Targets
11/06/2024 - 18:47 -
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
11/06/2024 - 20:50 -
Tevogen Bio Enters Into Agreement for Up to $50 Million in Financing to Advance R&D and Clinical Development Efforts
11/06/2024 - 21:30 -
Rhythm Pharmaceuticals Announces New Employment Inducement Grants
11/06/2024 - 22:01 -
Vera Therapeutics Appoints Christy J. Oliger to Board of Directors
11/06/2024 - 22:01 -
Neurona Therapeutics Appoints Dr. Manher Joshi as Chief Medical Officer
11/06/2024 - 22:05 -
PetMeds® Announces Its Fourth Quarter and Fiscal Year End Financial Results
11/06/2024 - 22:05 -
QIAGEN launches new QIAcuity digital PCR assays for microbial applications, enhancing infectious disease research and surveillance
11/06/2024 - 22:05 -
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social
11/06/2024 - 22:15 -
Voting Rights and Shares Capital of the Company
11/06/2024 - 22:15 -
Streamline Health® Reports Fiscal First Quarter 2024 Financial Results
11/06/2024 - 22:30 -
Panbela Announces Oral Presentation at Digestive Disease Week (DDW):
10/06/2024 - 14:00 -
Autonomix to Announce Preliminary Topline Results from First Five Lead-In Patients in Ongoing Human Clinical Trial on June 18, 2024
10/06/2024 - 14:00 -
Monopar Presents Data Showcasing the Appeal of uPAR as a Radiopharma Cancer Target and of its lead Clinical Program at the 2024 SNMMI Annual Meeting
10/06/2024 - 14:00 -
Sagimet Biosciences to Host Conference Call and Webcast to Discuss Recently Presented Data from ITT and F3 Patient Population in Phase 2b FASCINATE-2 Clinical Trial of Denifanstat
10/06/2024 - 14:00 -
LifeMD to Participate in the Truist Securities Healthcare Disruptors & Digital Health Summit
10/06/2024 - 14:00 -
Helio Genomics’ HelioLiver Dx Test Meets Coprimary and Secondary Study Endpoints in the CLiMB Trial, Presented at the EASL Congress 2024
10/06/2024 - 14:00 -
InnovAge Holding Corp. Announces $5.0 Million Share Repurchase Program
10/06/2024 - 14:00 -
Assembly Biosciences Doses First Participant in Phase 1a/b Clinical Trial of Herpes Simplex Virus Helicase-Primase Inhibitor Candidate ABI-5366
10/06/2024 - 14:00
Pages